BuybackJun 1, 2026, 07:57 AM
Novo Nordisk Repurchases DKK 4.71B B Shares, 0.8% of Capital
AI Summary
Novo Nordisk provided an update on its ongoing share repurchase program, which aims to repurchase up to DKK 15 billion in B shares over a 12-month period starting February 4, 2026. As of May 29, 2026, the company has repurchased B shares totaling DKK 4,713,270,686 since the program's inception. This includes DKK 913,270,696 under a specific sub-program initiated on May 6, 2026, which targets up to DKK 11.2 billion in repurchases. Novo Nordisk currently holds 35,074,480 B shares as treasury shares, accounting for 0.8% of its total share capital.
Key Highlights
- Novo Nordisk is executing an overall share repurchase program of up to DKK 15 billion, initiated on February 4, 2026.
- A sub-program, initiated May 6, 2026, aims to repurchase B shares up to DKK 11,200,000,010.45 by February 1, 2027.
- As of May 29, 2026, Novo Nordisk has repurchased DKK 4,713,270,686 worth of B shares since February 4, 2026.
- A total of 17,889,179 B shares have been repurchased at an average price of DKK 263.47 per share.
- Under the May 6, 2026 program, DKK 913,270,696 has been repurchased as of May 29, 2026.
- The company now holds 35,074,480 B shares as treasury shares, representing 0.8% of its share capital.
Price Impact
More from NVO